MétaCan
Menu
Back to cohort
Record W4392380532 · doi:10.1016/j.chest.2024.02.049

Use of Intravenous Albumin

2024· article· fi· W4392380532 on OpenAlexafffund
Nikolaos J. Skubas, Aarti Bathla, Homa Keshavarz, Edward G. Clark, Bram Rochwerg, Dean Fergusson, Sesmu Arbous, Seth R. Bauer, Louise China, Mark Fung, Rachel Jug, Michael Neill, Cary H. Paine, Katerina Pavenski, Prakesh S. Shah, Susan Robinson, Hua Shan, Zbigniew M. Szczepiorkowski, Thierry Thévenot, Bovey Wu, Simon Stanworth, Nadine Shehata

Bibliographic record

VenueCHEST Journal · 2024
Typearticle
Languagefi
FieldMedicine
TopicTrauma, Hemostasis, Coagulopathy, Resuscitation
Canadian institutionsUniversité de MontréalUniversity of British ColumbiaBruyèreOttawa HospitalUniversity Health NetworkCarleton UniversityTrillium Health CentreKingston Health Sciences CentreUniversity of OttawaMount Sinai HospitalCanadian Blood ServicesHamilton Health SciencesMcMaster UniversityQueen's University
FundersGrifolsOntario Regional Blood Coordinating NetworkBayer HealthCareCanadian Blood ServicesNHS Blood and TransplantIpsenUniversity of CincinnatiGilead SciencesCerus CorporationLoma Linda UniversityWorld Bank Group
KeywordsMedicineAlbuminCirrhosisIntensive care medicineRenal replacement therapySerum albuminIntravenous fluidSurgeryInternal medicine

Abstract

fetched live from OpenAlex

BACKGROUND: Albumin is used commonly across a wide range of clinical settings to improve hemodynamics, to facilitate fluid removal, and to manage complications of cirrhosis. The International Collaboration for Transfusion Medicine Guidelines developed guidelines for the use of albumin in patients requiring critical care, undergoing cardiovascular surgery, undergoing kidney replacement therapy, or experiencing complications of cirrhosis. STUDY DESIGN AND METHODS: Cochairs oversaw the guideline development process and the panel included researchers, clinicians, methodologists, and a patient representative. The evidence informing this guideline arises from a systematic review of randomized clinical trials and systematic reviews, in which multiple databases were searched (inception through November 23, 2022). The panel reviewed the data and formulated the guideline recommendations using Grading of Recommendations Assessment, Development, and Evaluation methodology. The guidelines were revised after public consultation. RESULTS: The panel made 14 recommendations on albumin use in adult critical care (three recommendations), pediatric critical care (one recommendation), neonatal critical care (two recommendations), cardiovascular surgery (two recommendations), kidney replacement therapy (one recommendation), and complications of cirrhosis (five recommendations). Of the 14 recommendations, two recommendations had moderate certainty of evidence, five recommendations had low certainty of evidence, and seven recommendations had very low certainty of evidence. Two of the 14 recommendations suggested conditional use of albumin for patients with cirrhosis undergoing large-volume paracentesis or with spontaneous bacterial peritonitis. Twelve of 14 recommendations did not suggest albumin use in a wide variety of clinical situations where albumin commonly is transfused. INTERPRETATION: Currently, few evidence-based indications support the routine use of albumin in clinical practice to improve patient outcomes. These guidelines provide clinicians with actionable recommendations on the use of albumin.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Other design · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.904
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.071
GPT teacher head0.308
Teacher spread0.237 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designOther design
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations66
Published2024
Admission routes2
Has abstractyes

Explore more

Same venueCHEST JournalSame topicTrauma, Hemostasis, Coagulopathy, ResuscitationFrench-language works237,207